Medicine shortages and glaucoma care: a time-series analysis indicating population-level consequences of a national timolol eye drop shortage
A retrospective time-series analysis of Australian dispensing data reveals that the 2024–2025 national timolol eye drop shortage significantly disrupted access to this first-line glaucoma treatment, with imported products providing only partial mitigation and failing to restore utilization to pre-shortage levels despite regulatory approval.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine your eyes have a tiny, delicate garden that needs constant watering to stay healthy. For many people with glaucoma (a condition that damages the eye's "garden"), a specific type of eye drop called Timolol is the main hose they use to keep the pressure just right. If the pressure gets too high, the garden suffers.
In 2024 and 2025, Australia faced a problem: the main hose (Timolol) suddenly ran dry across the entire country. This study, conducted by researchers from Adelaide and Flinders universities, looked at what happened to the "gardeners" (patients) and the "supply trucks" (pharmacies) during this drought.
Here is the story of what they found, explained simply:
1. The Great Drought (The Shortage)
Think of Timolol as a popular brand of water bottle that everyone relies on. In mid-2024, the factory stopped sending these bottles to Australia.
- First, the fancy bottles ran out: The "extended-release" version (a special bottle that lasts all day with just one drop) disappeared first.
- Then, the regular bottles ran out: People tried to switch to the "standard-release" version (which needs two drops a day) to cope, but those ran out too shortly after.
2. The Emergency Backup Plan (Imported Goods)
When the local shelves went empty, the government (the Therapeutic Goods Administration) tried to open a "backdoor" to get water from neighbors. They allowed three specific types of Timolol to be imported from the UK and South Africa under a special emergency rule called S19A.
Think of this like a neighbor lending you a different brand of water bottle because your usual one is gone.
- Did it work? Partially. These imported bottles saved the day for some people. At the peak of the shortage (March 2025), 87% of the Timolol being used was this "borrowed" water from overseas.
- The Catch: Even with the help from neighbors, the total amount of water people were using never got back to normal levels. It was like having a backup generator, but it still couldn't power the whole house as well as the main grid.
3. The "Switching" Game
When the main water bottle was gone, the researchers wondered: Did people just switch to a different brand of water entirely?
- They looked at other types of eye drops (like prostaglandin analogues).
- The Result: Not really. People didn't switch in large numbers. The study suggests that doctors and patients were hesitant to swap Timolol for a completely different type of medicine. It's like being told to switch from water to juice; you might do it for a moment, but if you have a specific health need, you might just go without rather than risk the change.
4. Why Didn't Everyone Get Their Medicine?
Even though the government approved these imported bottles, many people still couldn't get them. The researchers suggest a few reasons:
- Confusion: Some pharmacy staff didn't know these emergency bottles existed or how to order them.
- Mismatch: The imported bottles weren't always the exact same shape or size as the ones people were used to. If a patient is used to a specific bottle, they might be scared to try a new one.
- The "Wait and See" Problem: Pharmacies usually only order these special bottles after a customer asks for them. If the customer doesn't know to ask, or if the pharmacy is slow to order, the patient goes without.
5. The "60-Day" Rule Twist
Around the same time, the government changed a rule to let doctors prescribe a 60-day supply of medicine instead of 30 days. The researchers checked to see if this made the shortage worse (by people hoarding medicine). They found that for Timolol, this didn't happen much, but it might have caused issues for other eye medicines.
The Bottom Line
The study concludes that when a critical medicine like Timolol runs out, even emergency measures (like importing from other countries) only provide a partial fix.
- The "garden" (patients' eyes) didn't get the full amount of water it needed.
- The emergency imports helped, but they didn't fully replace the local supply.
- The researchers suggest that in the future, we need to be faster at approving these emergency imports and make sure the "borrowed" bottles look and feel exactly like the ones people are used to, so no one is left dry.
In short: The Timolol shortage was a major disruption. The government tried to patch the hole with imported supplies, but the patch wasn't big enough to stop the leak, and many patients still faced gaps in their treatment.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.